Cann-ID - Cloud-based Global Chem. Data Analytics

Industrywide Data Management Pl...


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

TRUSTED TEST, TRACK, AND TRACE
Market Opportunity

Market Size: Our global TAM exceeds $263B and is expected to increase by $12B by 2028.

Our Forecast:

TRUSTED TEST, TRACK, AND TRACE
Cann-ID: Fast Facts

Cann-ID is currently the most distributed decentralized chemical data testing and analytics network platform in the world. Our focus is in:

  • Cannabis
  • Psilocybin
  • Emerging Therapeutics (MDMA)

B2B, B2G and G2B organizations can confidently engage in production/ manufacturing and cross-border transportation with Cann-ID.

Cann-ID has the only successfully deployed de-centralized blockchain data security platform utilized in ISO 17035 Lab environments.

Cann-ID is an integral element to the market’s only Test Track Trace and Tax solution for government compliance, commerce, and tax applications.

Cann-ID was endorsed by industry groups representing over 90% of the US hemp industry. 

TRUSTED TEST, TRACK, AND TRACE
The Problem

Past

  • Government and Analysts:
    ▪ Underestimated ability of black market to hold market share
    ▪ Have limited ability to track and trace product from the field to end       user
  • No defined standardization, no product consistency
  • Lack of an effective tax revenue collection system
  • Ineffective current CTS (Cannabis Tracking Systems) which compromises business and regulation

Future

  • Opportunity to garner market share is now more compelling than ever (Pfizer)
  • Government and analyst estimates of market growth were correct – the market is enormous
  • Private industry,  government need to plan for interstate & international commerce

TRUSTED TEST, TRACK, AND TRACE
The Cann-ID Solution

Scalable - Not limited by borders, permits or hardware enabling industry-wide ease of adoption. 

Market-ready - The only combined “Test, Track, Trace, and Tax” (T4) solution for the emerging therapeutics industry. 

Pilot-tested - Cann-ID is currently deployed throughout the US and in 4 foreign countries. 

Cann-ID was endorsed as (BDAT) Best Developed & Available Technology by professional groups representing over 90% of US hemp industry. 

Completed one PPP (Public-Private-Partnerships) with Texas A&M. Finalizing two more country-wide PPPs.  In discussions with multiple domestic states and foreign governments for T4 national deployment.

TRUSTED TEST, TRACK, AND TRACE
How It Works

TRUSTED TEST, TRACK, AND TRACE
Cann-ID Makes Chemical 
Data Accessible 

Cann-ID is the pioneering solution for globally applied, scalable, cloud-based, decentralized chemical data acquisition, analytics, and management for the cannabis industry. 

By converging the best elements of Ag-tech, Reg-tech and Fin-tech applications, we allow the B2B and B2G sectors to collaborate and share highly accurate, near real time chemical data to streamline operational processes and support commercial and governments transactions.

 

* Cann-ID has the capability through AI/ML to aggregate every current and future COA into a single global database.

TRUSTED TEST, TRACK, AND TRACE
Cann-ID + SICPA
Supports The Cannabis
Industry Ecosystem

Cann-ID + SICPA meet the requirements for state and national solution requirements and gives the tools necessary for cannabis & psilocybin industries to mature.

Through our partnership with SICPA, we have created the first “Test, Track, Trace and Tax (T4)” data platform in the world. SICPA and Cann-ID   Cann-ID integrates seamlessly with the SICPATRACE® Compliance traceability framework.  CERTUS® protected test/ COA’s issued through Cann-ID are automatically captured in the SICPATRACE® Compliance Reporting Track & Trace Solution. It’s designed for government compliance and management of cannabis, including secure interstate/intrastate and international commerce of controlled substances and emerging therapeutics.

TRUSTED TEST, TRACK, AND TRACE
Meet The Team

David (Cree) Crawford, Co-Founder, President/COO, Business Development & Operations Entrepreneur, Strategist | Founder of multiple startups from zero to $1MM /month revenues. 

Alexander (Alex) Andrawes, Co-Founder, Executive Chairman. Co-founded the largest USA direct-to-consumer private label wine company

Susan Walton, Senior finance and digital media executive with 25+ years of experience in top tier consulting firms and investment banks in London, New York and Hong Kong

Shawn Helmueller MS, Chief Science Officer | Ran Cannabis program at Waters Corporation. Former Chief Science Officer at Deutsche Process (extraction/processor). Cannabis/hemp method development expertise.

Dr. Susan Audino, Sr. Advisor | Chaired the AOAC cannabis advisory panel. Instructor for multiple ISO/IEC standards.


 
John Moynihan, Special Government Advisor | Former head of criminal money laundering at the DEA. 
 

William T Reid IV, Legal Advisor | AUSA (Assistant United States Attorney). Managing partner of Reid Collins
 

Dan Peterson MD, Medical Advisor | Former Chief of Staff at Dell Seton Medical Center. Neurological Surgeon
 

Angela Grayson, IP Attorney | Technical Area: Pharma, Medical Device, Software. Education: B.S. Chemistry; M.S. Chemistry; J.D. Law. Former inhouse legal counsel to Walmart, DuPont, Pfizer, USPTO.

TRUSTED TEST, TRACK, AND TRACE
Our Partners

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.